s.silva
TL2 · Kochi
Contributes reviews on supplier material. Based in Kochi.
Joined 12 September 2024 · last posted 4d
80 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #92 · Analytics › COA interpretation · 24 Jul 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Journal club: what we got wrong in an earlier session Replied, post #112 · Evidence › Journal club · 23 Jul 2026 · 1 like Post #108 describes the usual case. This is about the unusual one. Sessions on negative or null results are consistently the most instructive and the hardest to get…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #27 · Evidence › Meta-analyses · 17 Jul 2026 · 18 likes Bookmarking this. I will come back when I have something worth adding.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #64 · Practice › Dosing & titration · 16 Jul 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #19 · Sourcing › Vendor reports · 14 Jul 2026 · 19 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #132 · Sourcing › Logistics · 12 Jul 2026 · 0 likes Picking up post #129: that is the part I would want checked first. Regional warehouse stock versus direct is a good example of a question where the honest answer is…
-
How much context is too much context in a first post? Replied, post #75 · Start Here › How to Ask · 10 Jul 2026 · 3 likes Post #74 is right about the mechanism and I think understates the practical bit. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Insurance and replacement policies, compared Replied, post #76 · Sourcing › Logistics · 9 Jul 2026 · 1 like The arithmetic on insurance and replacement policies is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and…
-
Aggregate verification data across the directory, with caveats Replied, post #34 · Sourcing › Independent verification · 8 Jul 2026 · 4 likes My position on aggregate verification data is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Stability of BPC-157 in solution: what has been measured Replied, post #3 · Compounds › Repair & healing peptides · 28 Jun 2026 · 1 like Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Pooling trials with different estimands Replied, post #52 · Evidence › Meta-analyses · 27 Jun 2026 · 10 likes Marking my place. If it changes for me I will come back and say so.
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #15 · Sourcing › Vendor reports · 17 Jun 2026 · 2 likes Worth separating two things that post #14 runs together. If the supplier was asked about a discrepancy, include what they said verbatim rather than summarised. The…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #23 · Practice › Administration · 13 Jun 2026 · 0 likes Answering the question post #19 raises rather than the one it answers. Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the…
-
Pages past their review date, listed — does this still hold? Replied, post #8 · Meta › Wiki maintenance · 10 Jun 2026 · 0 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #35 · Analytics › Home & field testing · 29 May 2026 · 3 likes I had written a reply contradicting post #33 and deleted it. Here is what survived. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #37 · Analytics › Home & field testing · 28 May 2026 · 31 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. That is the shape of it.…
-
Purity assay versus content assay: two different numbers Started this topic · Analytics › COA interpretation · 17 May 2026 · 46 likes On the subject in the title: Purity assay versus content assay: two different numbers Working notes rather than a conclusion. Asking about purity assay versus content…
-
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Replied, post #6 · Compounds › Secretagogues & GH axis · 13 May 2026 · 3 likes Post #5 is right about the mechanism and I think understates the practical bit. Why this subcategory is stricter about sourcing than most: the evidence base is weaker…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #63 · Sourcing › Vendor reports · 8 May 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Moderation log format change Replied, post #47 · Meta › Announcements · 24 Apr 2026 · 0 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Talking to a therapist about this specifically Started this topic · Wellbeing › Mental health · 20 Apr 2026 · 17 likes Posting this under the heading it deserves: Talking to a therapist about this specifically Everything below is what sits behind that. Something that has come up for me…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #14 · Practice › Administration · 12 Apr 2026 · 10 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Batch numbers that do not match the vial label Replied, post #4 · Sourcing › Red flags · 9 Apr 2026 · 30 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Journal club: is percentage weight change the right endpoint? Replied, post #24 · Evidence › Journal club · 30 Mar 2026 · 5 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
CJC-1295 with and without DAC: what the modification does Replied, post #19 · Compounds › Secretagogues & GH axis · 24 Mar 2026 · 5 likes Adding a small correction to the CJC-1295 summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Measurement error in home scales, with a worked standard deviation Replied, post #11 · Research Methods › Statistics · 21 Feb 2026 · 0 likes Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #50 · Practice › Interactions · 11 Feb 2026 · 8 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Trifluoroacetate content and its consequences Replied, post #99 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes Distinguishing three things in the trifluoroacetate content discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #18 · Compounds › Semaglutide · 1 Feb 2026 · 10 likes On formulation: the licensed product is buffered and includes a preservative in the multi-dose presentation. A reconstituted research preparation matches neither, and…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #22 · Analytics › Mass spectrometry · 30 Jan 2026 · 0 likes Post #18 and I disagree about the size of the effect, not about the direction. I have no financial interest in anything named in this thread and I want to say so before…
-
Heterogeneity as information rather than as a nuisance Replied, post #80 · Evidence › Meta-analyses · 28 Jan 2026 · 8 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search. I would put the…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #62 · Sourcing › Vendor reports · 26 Jan 2026 · 19 likes Post #59 is the version of this I will quote in future. One addition. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because…
-
Revisiting: Liver enzymes drifting down and what that usually means Started this topic · Clinical › Bloodwork · 26 Jan 2026 · 21 likes On the subject in the title: Revisiting: Liver enzymes drifting down and what that usually means Working notes rather than a conclusion. A methods question rather than…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #10 · Practice › Administration · 31 Dec 2025 · 10 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #16 · Regional › UK & Ireland · 27 Dec 2025 · 4 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Temperature loggers worth the money — the long version Replied, post #93 · Devices › Cold chain · 15 Dec 2025 · 0 likes On post #91 — agreed on the reasoning, with one qualification. Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They are the…
-
Cross-border purchase rules within the EU Replied, post #44 · Regional › European Union · 25 Nov 2025 · 2 likes Noted, and I have changed what I was going to do on the strength of it.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #17 · Outcomes › Body composition · 19 Nov 2025 · 19 likes Photographs under fixed lighting and posture are a genuine record and are the hardest of these to standardise. Written quickly, so the reasoning may be tighter than the…
-
Reading SURMOUNT-1 without the press release Replied, post #66 · Compounds › Tirzepatide · 14 Nov 2025 · 14 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Managing an unplanned gap in supply — what changed since Replied, post #104 · Access › Shortages · 1 Nov 2025 · 0 likes Confirming post #102 from a second method, which matters more than confirming it from a second person. Both are useful and different. The notice tells you the national…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #18 · Compounds › Tirzepatide · 31 Oct 2025 · 10 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Payment mechanics and the recovery options that do not exist Replied, post #42 · Sourcing › Payments · 20 Oct 2025 · 0 likes The strongest argument against my own position on payment mechanics, stated as well as I can state it, since nobody else has yet.
-
A 40-week log with the measurement method stated Replied, post #18 · Outcomes › Progress reports · 16 Oct 2025 · 3 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions.
-
Availability by country, dated, with primary sources Replied, post #18 · Access › International · 12 Oct 2025 · 23 likes This follows post #16 rather than contradicting it. Reading this availability thread as someone who came in with a fixed view: the third and seventh replies moved me…
-
Second pass at: Programming during a large energy deficit Replied, post #25 · Nutrition & Training › Resistance training · 2 Oct 2025 · 8 likes Deload weeks matter more during a deficit than at maintenance because recovery is the limiting factor. The reasoning is more useful than the number, which is why I have…
-
Substitution between formats during a shortage Replied, post #66 · Access › Shortages · 30 Sep 2025 · 29 likes The reason substitution between formats is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
-
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #5 · Practice › Dosing & titration · 23 Sep 2025 · 9 likes Adding the measurement that post #2 says would settle it. There is no published evidence about slower escalation because nobody studied it. That means the trials…
-
High-resolution MS on aggregates and what it can see Replied, post #71 · Analytics › Mass spectrometry · 18 Sep 2025 · 23 likes Post #67 put the caveat in the right place and I want to underline it. I read the earlier replies on high-resolution twice before writing this, because I had assumed…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #39 · Practice › Storage & stability · 30 Aug 2025 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
When a preprint is the best available evidence and we say so Replied, post #105 · Evidence › Preprints · 27 Aug 2025 · 23 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
A ten-fold dose error caught before injection — one year on Replied, post #152 · Devices › Syringes & needles · 5 Aug 2025 · 1 like The confident answers on ten-fold dose error caught and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #37 · Compounds › Secretagogues & GH axis · 5 Aug 2025 · 0 likes Post #34 answers the question as asked. The question underneath it is different. A mass result for a short peptide is more discriminating than for a long one, because a…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #15 · Wellbeing › Mental health · 22 Jul 2025 · 17 likes I disagree with the framing of Mood changes above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #14 · Analytics › HPLC & UHPLC · 21 Jul 2025 · 10 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Managing an unplanned gap in supply — what changed since Replied, post #15 · Access › Shortages · 11 Jul 2025 · 9 likes Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 3 likes Adding the measurement that post #38 says would settle it. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
-
Repeatability versus intermediate precision Replied, post #9 · Analytics › Method validation · 17 Jun 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Where a pharmacopoeial monograph exists, a method that follows it inherits a great…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #2 · Practice › Dosing & titration · 15 Jun 2025 · 24 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
-
Pre-registering a personal experiment, seriously Replied, post #102 · Research Methods › N-of-1 designs · 3 Jun 2025 · 15 likes No disagreement from me. Posting only so the question does not look ignored.
-
Pre-registering a personal experiment, seriously Replied, post #66 · Research Methods › N-of-1 designs · 31 May 2025 · 2 likes Two sentences on pre-registering a personal experiment and then I will stop, because the rest is speculation and the thread is better without mine. What is documented…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #107 · Sourcing › Independent verification · 17 May 2025 · 0 likes Building on post #104 rather than restating it. I have no financial interest in anything named in this thread and I want to say so before I comment on Janoshik, because…
-
Pages past their review date, listed — does this still hold? Replied, post #26 · Meta › Wiki maintenance · 11 May 2025 · 29 likes Post #25 describes the usual case. This is about the unusual one. Last maintenance note: the limitations section is the part most likely to be skipped and the part most…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #36 · Evidence › Journal club · 9 May 2025 · 12 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
Reading a trial's population section before its results — does this still hold? Replied, post #31 · Evidence › Trials · 22 Apr 2025 · 7 likes Narrowing post #28, because the general version has more than one answer. Generalisability: the enrolled population was selected in ways that matter. Entry criteria,…
-
Scheduled maintenance and what will be unavailable Replied, post #119 · Meta › Announcements · 22 Apr 2025 · 15 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced. Written in the hope of being told what I…
-
Sample size in a voluntary survey: the selection problem Replied, post #6 · Data & Tools › Datasets · 16 Apr 2025 · 16 likes Marking my uncertainty on sample size explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
-
Validating a method you did not develop — does this still hold? Replied, post #110 · Analytics › Method validation · 13 Mar 2025 · 0 likes Offering a way to settle Validating a method rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #68 · Evidence › Journal club · 27 Feb 2025 · 27 likes Adding the measurement that post #65 says would settle it. One caution on SURMOUNT-1: everything above assumes the underlying documentation is what it claims to be.…
-
Telehealth prescribing models in the US Replied, post #57 · Regional › North America · 11 Feb 2025 · 0 likes The denial letter is the specification for the appeal. It states a criterion and the job is to demonstrate that criterion in the letter's own language. That is one…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #75 · Compounds › Secretagogues & GH axis · 7 Feb 2025 · 0 likes Well-designed human trial is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
What changed in 2026, by region Replied, post #34 · Access › International · 22 Dec 2024 · 0 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Coming back to: When to suspect the method rather than the sample Replied, post #31 · Analytics › Method validation · 5 Dec 2024 · 8 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. Sample stability during analysis is part of validation and is routinely ignored. A…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #13 · Compounds › Oral incretins · 27 Nov 2024 · 7 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
-
Gallbladder disease risk with rapid weight loss Replied, post #29 · Clinical › Comorbidities · 10 Nov 2024 · 32 likes Narrowing post #26, because the general version has more than one answer. Gallbladder disease risk came up in a thread eighteen months ago and was answered well. I…
-
Time to steady state after a dose increase Replied, post #127 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 21 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #110 · Clinical › Bloodwork · 15 Oct 2024 · 0 likes I have been on both sides of the bring a laboratory argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Requesting a page: what makes a good request — what changed since Replied, post #71 · Documentation › Wiki requests · 11 Oct 2024 · 0 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #78 · Practice › Administration · 4 Oct 2024 · 1 like Post #75 put the caveat in the right place and I want to underline it. Rotate on a fixed sequence rather than choosing each week. A sequence you follow beats a scheme…
-
Irish differences from the UK position Replied, post #16 · Regional › UK & Ireland · 1 Oct 2024 · 13 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. Waiting times are the most variable and least generalisable thing…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #52 · Evidence › Journal club · 22 Jul 2024 · 0 likes The arithmetic in post #50 is right; the assumption feeding it is the part to check. The figures usually contain the finding and the text usually contains the…